Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $19

Benzinga · 12/01 13:17
Citizens analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $11 to $19.